Tag: European Commission

European Commission Grants Orphan Medicinal Product Designation to Karyopharm and Menarini Group

Sandy B

The European Commission has granted Orphan Medicinal Product Designation to Karyopharm Therapeutics Inc., a pharmaceutical company pioneering cancer therapies, and Menarini Group, a leading international pharmaceutical company, for selinexor used to treat myelofibrosis (MF). Selinexor was granted the orphan drug designation by the US Food and Drug Administration (FDA) in May 2022. Selinexor is currently […]

Continue Reading

European Commission Prohibits Acquisition of GRAIL by Illumina

Sandy B

The European Commission has prohibited the implemented acquisition of GRAIL by Illumina under the European Union Merger Regulation. The merger will reduce choice, and stifle innovation in the emerging market for early cancer detection tests. Illumina does not offer sufficient remedies to address these concerns. Margrethe Vestager, executive vice-president of the European Commission, said that […]

Continue Reading

European Commission Approved Roche’s ENSPRYNG as First and Only At-Home Treatment for NMOSD (neuromyelitis optica spectrum disorder)

Sandy B

On 28th June 2021, the company Roche announced, the European Commission has given the approval for ENSPRYNG for the purpose of treating the adolescents and the adults over 12 years of age, who are living with the anti-aquaporin-4 antibody (AQP4-IgG) seropositive neuromyelitis optica spectrum disorder (NMOSD). The treatment is going to be a monotherapy, or […]

Continue Reading